Concise synthesis and biological activities of 2α-alkyl- and 2α-(ω-hydroxyalkyl)-20-epi-1α,25-dihydroxyvitamin D 3

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 20, 2003, Pages 3503-3506

  Honzawa, Shinobu ^a   Suhara, Yoshitomo ^a,c   Nihei, Ken Ichi ^a   Saito, Nozomi ^a   Kishimoto, Seishi ^a   Fujishima, Toshie ^a   Kurihara, Masaaki ^b   Sugiura, Takayuki ^a   Waku, Keizo ^a   Takayama, Hiroaki ^a   Kittaka, Atsushi ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^c KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCITRIOL DERIVATIVE; GLUCOSE; VITAMIN D RECEPTOR;

ALKYLATION; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; EPIMERIZATION; HUMAN; HUMAN CELL; SUBSTITUTION REACTION;

EID: 10744224525     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00739-X     Document Type: Article

References (32)

1. DeLuca H.F. FASEB J. 2:1988;224.
2. Recent Advances in Vitamin D Chemistry and Pharmacological Activity. Uskokovic, M. R., Ed. Bioorg. Med. Chem. Lett. Symposia-in-print 1993, 3, 1775.
3. Jones G., Calverley M.J. Trends Endocrinol. Metab. 4:1993;297.
4. (a) Suhara Y., Nihei K., Kurihara M., Kittaka A., Yamaguchi K., Fujishima T., Konno K., Miyata N., Takayama H. J. Org. Chem. 66:2001;8760.
5. (b) Suhara Y., Nihei K., Tanigawa H., Fujishima T., Konno K., Nakagawa K., Okano T., Takayama H. Bioorg. Med. Chem. Lett. 10:2000;1129.
6. (a) Konno K., Fujishima T., Maki S., Liu Z.-P., Miura D., Chokki M., Ishizuka S., Yamaguchi K., Kan Y., Kurihara M., Miyata N., Smith C., DeLuca F.H., Takayama H. J. Med. Chem. 43:2000;4247.
7. (b) Konno K., Maki S., Fujishima T., Liu Z.-P., Miura D., Chokki M., Takayama H. Bioorg. Med. Chem. Lett. 8:1998;151.
8. For 2α-hydroxyalkoxyl series, see: (a) Kittaka A., Suhara Y., Takayanagi H., Fujishima T., Kurihara M., Takayama H. Org. Lett. 2:2000;2619 For our account, see: (b) Takayama, H.; Kittaka, A.; Fujishima, T.; Suhara, Y. In: Vitamin D Analogs in Cancer Prevention and Therapy: Recent Results in Cancer Research 164; Reichrath, J., Friedrich, M., Tilgren, W., Eds.; Springer-Verlag: Berlin, Heidelberg, 2003, p 289.
9. For 2α-hydroxyalkoxyl series, see: (a) Kittaka A., Suhara Y., Takayanagi H., Fujishima T., Kurihara M., Takayama H. Org. Lett. 2:2000;2619 For our account, see: (b) Takayama, H.; Kittaka, A.; Fujishima, T.; Suhara, Y. In: Vitamin D Analogs in Cancer Prevention and Therapy: Recent Results in Cancer Research 164; Reichrath, J., Friedrich, M., Tilgren, W., Eds.; Springer-Verlag: Berlin, Heidelberg, 2003, p 289.
10. Bouillon R., Okamura W.H., Norman A.W. Endocr. Rev. 16:1995;200.
11. Binderup L., Latini S., Binderup E., Bretting C., Calverley M.J., Hansen K. Biochem. Pharmacol. 42:1991;1569.
12. Dilworth F.J., Calverley M.J., Makin H.L.J., Jones G. Biochem. Pharmacol. 47:1994;987.
13. The crystal structures of the ligand binding domain (LBD) of VDR complexed to 1 and 4 resembled the conformations of LBD, even though the C20 methyl group demonstrated inverted geometry in LBD, see: Tocchini-Valentini G., Rochel N., Wurtz J.M., Mitschler A., Moras D. Proc. Natl. Acad. Sci. U.S.A. 98:2001;5491.
14. (a) Fujishima T., Liu Z.-P., Miura D., Chokki M., Ishizuka S., Konno K., Takayama H. Bioorg. Med. Chem. Lett. 8:1998;2145.
15. (b) Nakagawa K., Kurobe M., Ozono K., Konno K., Fujishima T., Takayama H., Okano T. Biochem. Pharmacol. 59:2000;691.
16. Fujishima T., Liu Z.-P., Konno K., Nakagawa K., Okano T., Yamaguchi K., Takayama H. Bioorg. Med. Chem. 9:2001;525.
17. Trost B.M., Dumas J., Villa M. J. Am. Chem. Soc. 114:1992;9836.
18. Wiggins L.S. Methods Carbohydr. Chem. 2:1963;188.
19. For example, this reaction proceeded only in 24% when n-BuMgCl was used in THF. Honzawa, S.; Yamamoto, Y.; Hirasaka, K.; Takayama, H.; Kittaka, A. Heterocycles, in press.
20. Fujishima T., Konno K., Nakagawa K., Kurobe M., Okano T., Takayama H. Bioorg. Med. Chem. 8:2000;123.
21. +) 444.3604, found 444.3594.
22. +) 458.3760, found 458.3765.
23. +) 472.3916, found 472.3909.
24. + 428.3291, found 428.3316.
25. +) 460.3552, found 460.3532.
26. +) 474.3709, found 474.3726.
27. + 470.3760, found 470.3763.
28. Imae Y., Manaka A., Yoshida N., Ishimi Y., Shinki T., Abe E., Suda T., Konno K., Takayama H., Yamada S. Biochim. Biophys. Acta. 1213:1994;302.
29. Collins S.J., Ruscetti F.W., Gallagher R.E., Gallo R.C. J. Exp. Med. 149:1979;969.
30. Discussion on biological activities and VDR binding affinity, see: Masuno H., Yamamoto K., Wang X., Choi M., Ooizumi H., Shinki T., Yamada S. J. Med. Chem. 45:2002;1825.
31. Kubodera N., Sato K., Nishii Y. Feldman D., Glorieux F.H., Pike J.W. Vitamin D. 1997;1071 Academic, New York.
32. Okano T., Nakagawa K., Kubodera N., Ozono K., Isaka A., Osawa A., Terada M., Mikami K. Chem. Biol. 7:2000;173.